Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNCT Phase I/II for Recurrent Head and Neck Malignancies
jRCTs061180067Phase 2Completed
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of boronophenylalanine in head and neck cancer (HNC) and melanoma. Primary endpoint: Tumor response at 6 months. Started Sep 2017; status: completed.
02
Drugs
boronophenylalanine
03
Conditions
head and neck cancer (HNC)melanoma
Beyond the preview
Go deeper on jRCTs061180067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061180067.